Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.
2.
3.

USP34 Regulated Human Pancreatic Cancer Cell Survival via AKT and PKC Pathways.

Gu Z, Lin C, Hu J, Xia J, Wei S, Gao D.

Biol Pharm Bull. 2019 Apr 1;42(4):573-579. doi: 10.1248/bpb.b18-00646. Epub 2019 Jan 26.

4.

The ubiquitin specific protease USP34 protects the ubiquitin ligase gp78 from proteasomal degradation.

Wang H, Ju D, Kho DH, Yang H, Li L, Raz A, Sun F, Xie Y.

Biochem Biophys Res Commun. 2019 Feb 5;509(2):348-353. doi: 10.1016/j.bbrc.2018.12.141. Epub 2018 Dec 22.

PMID:
30585151
5.

Expression and clinical significance of ubiquitin‑specific‑processing protease 34 in diffuse large B‑cell lymphoma.

Li C, Huang L, Lu H, Wang W, Chen G, Gu Y, Zhou Q, Peng Z, Feng Z.

Mol Med Rep. 2018 Nov;18(5):4543-4554. doi: 10.3892/mmr.2018.9447. Epub 2018 Sep 3.

PMID:
30221700
6.

Ubiquitin-specific protease USP34 controls osteogenic differentiation and bone formation by regulating BMP2 signaling.

Guo YC, Wang MY, Zhang SW, Wu YS, Zhou CC, Zheng RX, Shao B, Wang Y, Xie L, Liu WQ, Sun NY, Jing JJ, Ye L, Chen QM, Yuan Q.

EMBO J. 2018 Oct 15;37(20). pii: e99398. doi: 10.15252/embj.201899398. Epub 2018 Sep 4.

7.

Prenatal diagnosis of a 3.2-Mb 2p16.1-p15 duplication associated with familial intellectual disability.

Chen CP, Chern SR, Wu PS, Chen SW, Lai ST, Chuang TY, Chen WL, Yang CW, Wang W.

Taiwan J Obstet Gynecol. 2018 Aug;57(4):578-582. doi: 10.1016/j.tjog.2018.06.018.

8.

Chromosome 2 Microdeletion Syndrome in a Newborn with Amniotic Band Sequence.

Mallett T, McElroy M, Swift K, Reuter S.

S D Med. 2018 Apr;71(4):154-157.

PMID:
29996031
9.

A Screening Approach to Identify Clinically Actionable Variants Causing Congenital Heart Disease in Exome Data.

Szot JO, Cuny H, Blue GM, Humphreys DT, Ip E, Harrison K, Sholler GF, Giannoulatou E, Leo P, Duncan EL, Sparrow DB, Ho JWK, Graham RM, Pachter N, Chapman G, Winlaw DS, Dunwoodie SL.

Circ Genom Precis Med. 2018 Mar;11(3):e001978. doi: 10.1161/CIRCGEN.117.001978.

PMID:
29555671
10.

Molecular and clinical delineation of 2p15p16.1 microdeletion syndrome.

Lévy J, Coussement A, Dupont C, Guimiot F, Baumann C, Viot G, Passemard S, Capri Y, Drunat S, Verloes A, Pipiras E, Benzacken B, Dupont JM, Tabet AC.

Am J Med Genet A. 2017 Aug;173(8):2081-2087. doi: 10.1002/ajmg.a.38302. Epub 2017 Jun 1.

PMID:
28573701
11.

Inhibition of ubiquitin-specific protease 34 (USP34) induces epithelial-mesenchymal transition and promotes stemness in mammary epithelial cells.

Oh E, Kim JY, Sung D, Cho Y, Lee N, An H, Kim YJ, Cho TM, Seo JH.

Cell Signal. 2017 Aug;36:230-239. doi: 10.1016/j.cellsig.2017.05.009. Epub 2017 May 10.

PMID:
28499884
12.

Pathogenic variants screening in seventeen candidate genes on 2p15 for association with ankylosing spondylitis in a Han Chinese population.

Wang M, Xin L, Cai G, Zhang X, Yang X, Li X, Xia Q, Wang L, Xu S, Xu J, Shuai Z, Ding C, Pan F.

PLoS One. 2017 May 11;12(5):e0177080. doi: 10.1371/journal.pone.0177080. eCollection 2017.

13.

Identifying candidate genes for 2p15p16.1 microdeletion syndrome using clinical, genomic, and functional analysis.

Bagheri H, Badduke C, Qiao Y, Colnaghi R, Abramowicz I, Alcantara D, Dunham C, Wen J, Wildin RS, Nowaczyk MJ, Eichmeyer J, Lehman A, Maranda B, Martell S, Shan X, Lewis SM, O'Driscoll M, Gregory-Evans CY, Rajcan-Separovic E.

JCI Insight. 2016 Mar 17;1(3):e85461. doi: 10.1172/jci.insight.85461.

14.
15.

A de-novo interstitial microduplication involving 2p16.1-p15 and mirroring 2p16.1-p15 microdeletion syndrome: Clinical and molecular analysis.

Mimouni-Bloch A, Yeshaya J, Kahana S, Maya I, Basel-Vanagaite L.

Eur J Paediatr Neurol. 2015 Nov;19(6):711-5. doi: 10.1016/j.ejpn.2015.07.013. Epub 2015 Aug 4.

PMID:
26278498
16.

An association study between USP34 and polycystic ovary syndrome.

Zhao S, Tian Y, Zhang W, Xing X, Li T, Liu H, Huang T, Ning Y, Zhao H, Chen ZJ.

J Ovarian Res. 2015 May 15;8:30. doi: 10.1186/s13048-015-0158-y.

17.

Characteristics of 2p15-p16.1 microdeletion syndrome: Review and description of two additional patients.

Shimojima K, Okamoto N, Yamamoto T.

Congenit Anom (Kyoto). 2015 Aug;55(3):125-32. doi: 10.1111/cga.12112. Review.

PMID:
25900130
18.

Quality assurance test of delivered dose uniformity of multiple-dose inhaler and dry powder inhaler drug products.

Tsong Y, Dong X, Shen M, Lostritto RT.

J Biopharm Stat. 2015;25(2):328-38. doi: 10.1080/10543406.2014.972510.

PMID:
25357132
19.

Identifying USPs regulating immune signals in Drosophila: USP2 deubiquitinates Imd and promotes its degradation by interacting with the proteasome.

Engel E, Viargues P, Mortier M, Taillebourg E, Couté Y, Thevenon D, Fauvarque MO.

Cell Commun Signal. 2014 Jul 16;12:41. doi: 10.1186/s12964-014-0041-2.

20.

Haploinsufficiency of XPO1 and USP34 by a de novo 230 kb deletion in 2p15, in a patient with mild intellectual disability and cranio-facial dysmorphisms.

Fannemel M, Barøy T, Holmgren A, Rødningen OK, Haugsand TM, Hansen B, Frengen E, Misceo D.

Eur J Med Genet. 2014 Sep;57(9):513-9. doi: 10.1016/j.ejmg.2014.05.008. Epub 2014 Jun 7.

PMID:
24911659

Supplemental Content

Loading ...
Support Center